Agilus Diagnostics is the largest diagnostics service provider in terms of number of laboratories and the second largest in terms of revenue from operations
MUMBAI, Oct 1 (The CONNECT) - Diagnostic service provider Agilus Diagnostics Limited filed its Draft Red Herring Prospectus (DRHP) with market regulator Securities and Exchange Board of India (SEBI) for its IPO.
The Company plans to raise funds through initial public offerings of Equity Shares with a face value ₹ 10 each. The total offering comprises of offer for sale up to 14,233,964 Equity Shares by Selling Shareholders.
The Company is the largest diagnostics service provider in terms of number of laboratories and the second largest in terms of revenue from operations in India as of and for the financial year ended March 31, 2023 as per a CRISIL Report.
The Equity Shares are proposed to be listed on the BSE Limited (BSE) and National Stock Exchange of India Limited (NSE).
ICICI Securities Limited, Axis Capital Limited & Citigroup Global Markets India Private Limited are the Book Running Lead Managers to the issue.
The Company offers diagnostics testing services, including specialized tests, wellness and preventive care packages, hospital laboratory management services and clinical research trial testing services.
As of March 31, 2023, we had a network of 413 laboratories out of which 43 laboratories were accredited by National Accreditation Board for Testing and Calibration Laboratories (NABL), which according to the CRISIL Report, is the largest network of NABL accredited laboratories in India, as of March 31, 2023.
The company also has an international presence across the Middle East, Sub-Saharan Africa, Commonwealth of Independent States and the South Asian Association for Regional Cooperation (SAARC) region. In Fiscal 2023, we performed 39.07 million tests and served 16.62 million patients in India and internationally.
Its diagnostics laboratory network comprises one central global reference laboratory (GRL) at Mumbai in Maharashtra, five regional reference laboratories (RRLs) and 407 other clinical laboratories (including 403 pathology laboratories and four radiology centers). In addition, It has wellness centers, three Centers of Excellence (CoEs), 3,757 customer touch points (comprising patient service centers, collection centers and laboratories with walk-in facilities) and over 12,000 pick-up points.